Delhi-based Panacea Biotec has secured an order worth $222.32 million from the United Nations Children’s Fund (UNICEF) for supply of its EasyFive (pentavalent vaccine) for three years viz., 2010, 2011 and 2012.
The company has received an award notification for the same from UNICEF.
EasyFive, world’s first fully liquid pentavalent vaccine, is used to immunize childrens against Diptheria, Tetanus, wholecellPertussis, Hepatitis B and Hemophilus Influenza Type b.
In January 2005, the company had introduced this vaccine in India.
Panacea Biotec is the second largest vaccine producer of India and is also amongst the top 50 pharmaceutical companies in the country. Its state of the art manufacturing facilities for vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SA-MCC and WHO-cGMP standards.